Skip to main content
Caplight Logo









Belenos Biosciences Inc.

Belenos Biosciences Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://belenosbio.com/

Last Round

VC Round

Jul 17, 2024

Est. Valuation

$68.58M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Belenos Biosciences Inc. is a biotechnology company developing a pipeline of long-acting bispecific antibodies designed to transform the treatment of chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

bispecific antibodychronic inflammatory diseaselong-acting therapeuticsdrug in-licensingclinical-stage biotechdual-target therapyantibody therapyasthma treatmentatopic dermatitis treatmentChina-out licensingbiologicsTSLP inhibitorIL-13 inhibitorCOPD treatmentchronic rhinosinusitis with nasal polypsCRSwNP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Belenos Biosciences Inc. Comparables

Compare Belenos Biosciences Inc. with similar companies based on industry and business-model similarity.

Belenos Biosciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Windward Bio
81%
Uniquity Bio
80%
Aclaris Therapeutics
78%

Belenos Biosciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 17, 2024

Key People

Founding team and executive leadership

Megan M. Dow

Chief Operating Officer, Co-Founder

Founding Team

Tania Dimitrova

Co-founder & Chief Financial Officer

Founding Team

Donnie McGrath

Chief Executive Officer

Executive Team

Belenos Biosciences Inc. Investors

Notable investors and investment history

Belenos Biosciences Inc. investors
InvestorRounds
OrbiMedVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2026

    Grew 36% QoQ, from 11 to 15 employees.

  • Jul 20, 2025

    Grew 700% QoQ from 1 to 8 employees.

Belenos Biosciences Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Belenos Biosciences Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Belenos Biosciences Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range15
Year Founded2024
Last FundingJul 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.